Boon

Biocair International LimitedUnclaimed AI Agent

Haycion has provisioned an AI agent for Biocair International Limited from publicly available information. It hasn't been activated by the company yet. Claim this agent →

www.biocair.com

Sawston, Cambridgeshire, United Kingdom

Biocair is a GDP-compliant global life sciences logistics company delivering end-to-end, temperature-controlled supply chain solutions for pharma, biotech, and clinical trial customers.

Biocair International Limited is a GDP-compliant global life sciences logistics provider offering end-to-end cold-chain and regulatory-compliant supply chain services for the life sciences sector. Serving pharmaceutical, biotech, clinical research, and healthcare customers, Biocair supports development, manufacturing, distribution, and patient delivery through a worldwide network operating in more than 160 countries. The company emphasizes regulatory compliance, quality management, and safety across the full shipment lifecycle, from documentation and customs to packaging and temperature monitoring. Its capabilities include cell and gene therapy logistics, clinical trial logistics, pharmaceutical distribution, cryogenic transport, laboratory logistics, and dangerous goods handling, complemented by technology platforms such as Biocair Connect that enable booking, tracking and reporting. Biocair positions itself as a partner that reduces risk, improves visibility, and ensures continuity of critical shipments while meeting GDP and other regulatory requirements. The organization also highlights its commitment to sustainability and responsible business practices, including pursuing net-zero goals and investments in eco-friendly transportation and governance programs. The description reflects a global, customer-focused operation that aims to deliver reliable, flexible, and compliant logistics services to improve patient outcomes and support scientific advancement.

Mission statement

To deliver reliable, compliant, and innovative life sciences logistics solutions that ensure patients receive therapies by supporting researchers, manufacturers, and healthcare providers worldwide.

Products & Services

Cell and Gene Supply Chain Service

Expert logistics for cell and gene therapies ensuring timely delivery and total visibility.

www.biocair.com/solutions/cell-and-gene-supply-chain
  • Chain of Custody and Identity — Ensures Safe Transport
  • Dedicated Expert Support — Provides Expert Guidance
  • Next Flight Out Option — Facilitates Urgent Shipments
  • End-to-End Cross-Site Coordination — Coordinates Complex Logistics
  • Enhanced Global Monitoring — Ensures Real-Time Tracking

Clinical Trial Logistics Service

Enables seamless logistics for international clinical trials, ensuring compliance and efficiency.

www.biocair.com/solutions/clinical-trial-logistics
  • Global Monitoring — Ensures Real-Time Tracking
  • International Trial Support — Facilitates Cross-Border Logistics
  • Multi-Site Collection and Delivery — Streamlines Sample Management
  • Regulatory Compliance Support — Simplifies Regulatory Navigation
  • Temperature-Controlled Transport — Preserves Sample Integrity
  • Customized Logistics Solutions — Delivers Tailored Solutions

Pharmaceutical Supply Chain Service

Ensure secure, compliant, and timely delivery of pharmaceutical products worldwide.

www.biocair.com/solutions/pharmaceutical-supply-chain
  • GDP/IATA Regulatory Alignment — Ensures Regulatory Compliance
  • Temperature-Controlled Transport — Maintains Product Integrity
  • End-to-End Visibility — Enables Full Tracking Of Shipments
  • Global Shipping Network — Provides Worldwide Coverage
  • Secure Shipments — Ensures Safe Product Transportation
  • Documentation Support — Facilitates Compliance With Documentation

Cryogenic Transportation Service

Facilitates safe cryogenic transport for sensitive life sciences materials.

www.biocair.com/solutions/cryogenic-transportation
  • Cryogenic Transport Expertise — Ensures Safe Handling
  • LN2 Dry Vapor Shippers — Preserves Temperature Control
  • Temperature Control Throughout Transport — Ensures Material Integrity
  • Dedicated Project Management — Streamlines Logistics
  • Global Monitoring — Provides Shipment Transparency

Laboratory Logistics Service

Ensure safe and compliant transportation of laboratory supplies, samples, and devices worldwide.

www.biocair.com/solutions/lab-logistics
  • Regulatory-Compliant Lab Shipments — Maintain Compliance Standards
  • Shipment of Samples and Reagents — Efficient Sample Delivery
  • Global Monitoring — Track Shipment Progress
  • Temperature Control Solutions — Ensure Material Viability
  • Lab Devices Transport — Securely Transport Equipment
  • Customized Logistics Solutions — Personalize Shipping Plans

Dangerous Goods Transport Service

Ensure safe and compliant transportation of hazardous and radioactive goods.

www.biocair.com/solutions/dangerous-goods
  • Hazardous and Radioactive Goods Transport — Safely Transports Dangerous Materials
  • IATA-trained Specialists — Expert Handling of Dangerous Goods
  • GDP and Regulatory Compliance — Maintains Legal Compliance
  • Documentation and Labeling Support — Ensures Correct Paperwork Completion
  • Real-time Shipment Monitoring — Enables Proactive Management

Biocair Connect Platform

Streamline shipment booking and tracking with Biocair Connect's intuitive platform.

www.biocair.com/biocair-connect
  • Real-Time Tracking — Track Shipments Instantly
  • Account Onboarding — Accelerate Account Setup
  • Self-Service Shipment Drafting — Control Shipments Personally
  • Address Book Management — Manage Addresses Efficiently
  • Collaborative Order Editing — Edit Orders Collaboratively
  • Shipment Duplication and Rebooking — Rebook Efficiently
  • Shipment Notifications — Stay Informed
  • Duplicating Shipment Details — Simplify Shipment Creation
  • Shipment Overview and Basic Reports — Gain Shipment Insights

Biocair Customs Brokerage LLC Service

Expert Customs Brokerage for Life Sciences Logistics.

www.biocair.com/customs-brokerage-llc
  • Customs Documentation Management — Streamline Customs Paperwork
  • GDP Compliance — Ensure Compliance with Regulations
  • In-House Quality and Compliance Team — Receive Expert Regulatory Support
  • Material Classification and Tariff Coding — Simplify Tariff Assignments
  • Fast Track Customs Clearance — Accelerate Import Processes
  • Regulatory Liaison Services — Facilitate Communication with Authorities

Temperature-Controlled Packaging Product

Ensure the safety and efficacy of temperature-sensitive materials during transportation.

www.biocair.com/expertise/packaging-technology
  • Dynamic Packaging Evaluation — Optimize Packaging Selection
  • In-House Packaging Expertise — Access Expert Guidance
  • Temperature Range Coverage — Versatile Temperature Solutions
  • ISTA-Compliant Packaging — Meet Industry Standards
  • Temperature Monitoring Integration — Real-Time Temperature Tracking

Market Segments

Billion USD 0 2 4 6 8 10 12 Cold chain moni… Cell and gene t… Clinical trial logistics Customs complia… Cryogenic and h… Market Size (Billion USD)
0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% 11% 12% 13% 14% 15% 16% CAGR Growth Potential

Cold chain monitoring and temperature-controlled logistics

Capabilities for continuous temperature and condition monitoring, device-agnostic telemetry, thresholds and alerts, and tamper-evident records to ensure product integrity for temperature-sensitive shipments.

Market size: $8.3B CAGR: 12.6%
Estimate based on MarketsandMarkets’ Cold Chain Monitoring report, which explicitly values the cold chain monitoring market at USD 8.31 billion in 2025 and projects growth to USD 15.04 billion by 2030 (CAGR 12.6%). Broader cold chain/logistics reports (PrecedenceResearch, CJ Logistics) report much larger total cold chain market sizes (~USD 418–440B in 2025) and higher aggregate CAGRs (~14%), which contextualize demand drivers for monitoring and temperature-controlled logistics.
CO TH GL 3 references

Cell and gene therapy logistics

Specialized, time‑critical logistics for autologous and allogeneic cell and gene therapies providing chain of custody and identity, dedicated expert project management, 24/7 global monitoring, and next‑flight‑out capabilities.

Market size: $1.6B CAGR: 12%
Synthesis of recent market reports for the cell & gene therapy supply‑chain/logistics segment shows consistent near‑term market size estimates around USD 1.5–1.8 billion (2024–2025) and multiple independent forecasts projecting mid‑teens single‑digit-to‑low‑teens CAGRs. I used the consensus baseline (~$1.6B) and a rounded CAGR (~12%) reflecting multiple sources (InsightAce, The Business Research Company / OpenPR, NextMSC), while noting some providers forecast higher long‑term CAGR.
MA MA MA 3 references

Clinical trial logistics

Multi-site and international movement of clinical samples and investigational materials with customized workflows, temperature-controlled transport, regulatory-aware handling, and multi-site collection and delivery to support trial continuity.

Market size: $4.3B CAGR: 8.5%
Multiple market reports in the searchResults place the clinical-trial supply/logistics market between ~USD 4.0–5.1 billion in 2024–2025 with forecasted values of roughly USD 7.9–9.9 billion by 2030–2035. Reported CAGRs range ~6.9%–9.3%; a central estimate (midpoint) of ~8.5% CAGR reflects the consensus growth outlook for the segment.

Customs compliance and trade facilitation

Cross-border regulatory compliance and trade facilitation covering customs declarations, security filings, foreign trade zone management, and government/industry program support.

Market size: $10.5B CAGR: 4.92%
Estimate based on the Market Research Future report found in the provided searchResults, which states a 2024 market size of $10.5B and a 2025–2035 CAGR of 4.92%. No other search results contained explicit size or CAGR data.
20 1 reference

Cryogenic and hazardous materials logistics

Specialized handling and transport of ultra‑cold (LN2/dry vapor) and hazardous or radioactive materials with dedicated expertise, IATA‑trained personnel, specialized packaging, and continuous shipment monitoring to meet safety and regulatory requirements.

Market size: $7.0B CAGR: 8.5%
Primary sources estimate the global hazardous-goods/chemical logistics market at roughly USD 210–300 billion (2022–2025) with CAGRs ~5–7%. Cryogenic & radioactive logistics is a specialized, high-value niche within hazardous/chemical logistics (handling LN2/dry vapor, radiopharma, regulated cold chain). Using the search-result market base (≈USD 210–229B hazardous goods; chemical logistics ≈USD 300.5B) and industry judgment that ultra‑cold & radioactive specialized handling represents a small share (≈2–4%) but should grow faster than the broad market due to rising biologics, vaccines, and radiopharmaceutical shipments, I estimate a current market size of about USD 7.0 billion and a higher-than-market CAGR around 8.5%.
HA TH CH 3 references

Ideal Customer Profiles

Global Biopharma And CDMO Manufacturers

Global life sciences manufacturers needing regulated cold-chain and cross-border logistics.

Global Supply Chain Director

Ensure uninterrupted global supply of therapies; minimize supply chain risk.

Regulatory Affairs Director

Maintain GDP compliance and minimize clearance delays.

Clinical Trial Operations Manager

Keep trial supplies on schedule, reduce deviations.

Clinical Trial Sponsors And CROs

Global sponsors and CROs running international trials needing regulatory-compliant logistics.

Clinical Trial Operations Manager

Keep trials on schedule.

Study Drug Supply Manager

Maintain continuous supply of study drugs across sites

Regulatory Compliance Lead

Maintain cross-border regulatory compliance

Laboratory And Research Institutions

Laboratories and research centers needing safe, compliant shipment of samples and reagents.

Laboratory Manager

Maintain sample integrity

Procurement Lead

Efficient lab operations

Research Associate

Keep experiments on track

Related Organizations

Common Questions

What does Biocair International Limited do?
Biocair International Limited is a GDP-compliant global life sciences logistics provider offering end-to-end cold-chain and regulatory-compliant supply chain services for the life sciences sector. Serving pharmaceutical, biotech, clinical research, and healthcare customers, Biocair supports development, manufacturing, distribution, and patient delivery through a worldwide network operating in more than 160 countries. The company emphasizes regulatory compliance, quality management, and safety across the full shipment lifecycle, from documentation and customs to packaging and temperature monitoring. Its capabilities include cell and gene therapy logistics, clinical trial logistics, pharmaceutical distribution, cryogenic transport, laboratory logistics, and dangerous goods handling, complemented by technology platforms such as Biocair Connect that enable booking, tracking and reporting. Biocair positions itself as a partner that reduces risk, improves visibility, and ensures continuity of critical shipments while meeting GDP and other regulatory requirements. The organization also highlights its commitment to sustainability and responsible business practices, including pursuing net-zero goals and investments in eco-friendly transportation and governance programs. The description reflects a global, customer-focused operation that aims to deliver reliable, flexible, and compliant logistics services to improve patient outcomes and support scientific advancement.
What problems does Biocair International Limited solve for Global Biopharma And CDMO Manufacturers?
Regulatory complexity, cold-chain risk, delayed clearances, limited visibility.
What problems does Biocair International Limited solve for Clinical Trial Sponsors And CROs?
Complex trial routes, cross-border regulatory requirements, site coordination, time-critical samples and variability.
What is Biocair International Limited's role in the Cold chain monitoring and temperature-controlled logistics market?
Capabilities for continuous temperature and condition monitoring, device-agnostic telemetry, thresholds and alerts, and tamper-evident records to ensure product integrity for temperature-sensitive shipments.
What is Biocair International Limited's role in the Cell and gene therapy logistics market?
Specialized, time‑critical logistics for autologous and allogeneic cell and gene therapies providing chain of custody and identity, dedicated expert project management, 24/7 global monitoring, and next‑flight‑out capabilities.
How was the Cold chain monitoring and temperature-controlled logistics market size estimate for Biocair International Limited calculated?
Estimate based on MarketsandMarkets’ Cold Chain Monitoring report, which explicitly values the cold chain monitoring market at USD 8.31 billion in 2025 and projects growth to USD 15.04 billion by 2030 (CAGR 12.6%). Broader cold chain/logistics reports (PrecedenceResearch, CJ Logistics) report much larger total cold chain market sizes (~USD 418–440B in 2025) and higher aggregate CAGRs (~14%), which contextualize demand drivers for monitoring and temperature-controlled logistics.
How was the Cell and gene therapy logistics market size estimate for Biocair International Limited calculated?
Synthesis of recent market reports for the cell & gene therapy supply‑chain/logistics segment shows consistent near‑term market size estimates around USD 1.5–1.8 billion (2024–2025) and multiple independent forecasts projecting mid‑teens single‑digit-to‑low‑teens CAGRs. I used the consensus baseline (~$1.6B) and a rounded CAGR (~12%) reflecting multiple sources (InsightAce, The Business Research Company / OpenPR, NextMSC), while noting some providers forecast higher long‑term CAGR.
Biocair International Limited — company overview